Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models
Journal of Evidence-Based Medicine · 2026
DOI: 10.1111/jebm.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Evidence-Based Medicine, 2026. Verfasst von Fan Jia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Machine Learning. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Accurate subtyping of lung cancer is crucial for developing personalized treatment plans and improving patient outcomes. This study established machine learning models for lung cancer subtyping by integrating multidimensional hematological indicators, offering advantages such as non‐invasiveness, repeatability, and the capability for dynamic disease monitoring. The study utilized data from 771 lung cancer patients for model construction and validation, and an additional 510 independent cases were collected to assess the clinical applicability of the models. Ten supervised learning algorithms were screened, ultimately identifying the XGBoost model as optimal for differentiating small cell lung cancer from non‐small cell lung cancer, and the Random Forest model as optimal for distinguishing lung squamous cell carcinoma from lung adenocarcinoma. In the independent clinical validation cohorts from two centers, these two models achieved accuracies of 95% and 91%, respectively, demonstrating good clinical applicability and serving as a valuable complement to pathological biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Zitieren
APA
Jia, F., Xu, J., Zeng, L., Sun, S., Zheng, N., Zheng, W., Li, Y., Du, C., Yin, X., Huang, Y., Yang, X., Yuan, F., Li, B., & Li, B. (2026). Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70119
Vancouver
Jia F, Xu J, Zeng L, Sun S, Zheng N, Zheng W, et al. Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models. Journal of Evidence-Based Medicine. 2026. doi:10.1111/jebm.70119
BibTeX
@article{Jia2026,
author = {Jia, Fan and Xu, Jianmin and Zeng, Lijun and Sun, Shixin and Zheng, Naxin and Zheng, Wenwen and Li, Ying and Du, Chenran and Yin, Xiuyun and Huang, Yuan and Yang, Xuemei and Yuan, Fang and Li, Boan and Li, Bo},
title = {Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
doi = {10.1111/jebm.70119}
}
EUVIMED